Search

everythinglearnresearchcommunity

for

Search:↓

Treating both the mind and skin together, especially by managing stress, can greatly improve outcomes for skin disorders linked to psychological issues.

Hair diseases can have psychological effects and should be treated with a combination of psychosomatic care, therapy, and medication.

The paper suggests that a decrease in estrogen receptor activity may cause sexual dysfunction syndromes and proposes hormonal treatments.

People with alopecia areata have a higher risk of depression and anxiety, and often face unemployment and work absences.

The conclusion is that careful management of both psychiatric and skin conditions is crucial for HIV patients, using medication and interdisciplinary approaches.

Stopping the antidepressant agomelatine improved hair loss in a patient.

Transgender and gender-diverse adults on hormone therapy often face drug-hormone interactions, especially with multiple psychotropic medications.

A teenager lost hair due to fluoxetine and sertraline, but it grew back after stopping these drugs and switching to a different one.

Stopping aripiprazole can reverse its side effect of hair loss.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Certain drugs can cause male infertility, so fertility counseling and sperm preservation are advised.

New medications are improving depression treatment, emphasizing accurate diagnosis and chronic care.

SSRIs may help manage sexual behavior in dementia patients, but they can cause long-lasting sexual dysfunction.

People with migraines often have mental health conditions, and treatment should be personalized to address both issues safely.

Early screening and a mix of treatments help manage postpartum depression.

Cirrhosis affects quality of life with various symptoms, requiring a holistic, multidisciplinary approach for management.

Hair loss drugs like finasteride may cause lasting sexual and mood side effects, and more research is needed to understand these risks.

Certain steroids in the brain affect mood and symptoms of depression, and treatments targeting these steroids show promise for improving these symptoms.

SSRIs can cause hair loss, especially sertraline, with higher risk in women.

Psychotropic medications can cause skin problems, including serious conditions, and patients should be monitored closely.

A patient's allergic reaction to clozapine resolved without stopping the medication, showing the importance of blood monitoring.

Some medications may cause lasting sexual dysfunction.

Flibanserin shows promise for treating male sexual dysfunction but has side effects like insomnia and fatigue.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Many skin patients have mental health issues, but few dermatologists are well-versed in treating these conditions.

Inositol was not more effective than a placebo in treating trichotillomania.

The article concludes that dermatologists should prescribe lifestyle drugs carefully and consider mental health treatments for patients with disorders like BDD.

The review found that individualized treatment and teamwork are important for trichotillomania, and patients who followed through with treatment often improved.

Family-based treatment is the best outpatient care for stable teens with anorexia, and more research is needed on medication and treatment effectiveness for young people with eating disorders.

Women with schizophrenia on atypical antipsychotics are more likely to have polycystic ovarian syndrome (PCOS) than women without schizophrenia.